SAN

80.32

-2.62%↓

UCB

262.5

-1.06%↓

SHL.DE

35.91

-0.08%↓

ARGX

649

+0.53%↑

VIE

33.44

+0.3%↑

SAN

80.32

-2.62%↓

UCB

262.5

-1.06%↓

SHL.DE

35.91

-0.08%↓

ARGX

649

+0.53%↑

VIE

33.44

+0.3%↑

SAN

80.32

-2.62%↓

UCB

262.5

-1.06%↓

SHL.DE

35.91

-0.08%↓

ARGX

649

+0.53%↑

VIE

33.44

+0.3%↑

SAN

80.32

-2.62%↓

UCB

262.5

-1.06%↓

SHL.DE

35.91

-0.08%↓

ARGX

649

+0.53%↑

VIE

33.44

+0.3%↑

SAN

80.32

-2.62%↓

UCB

262.5

-1.06%↓

SHL.DE

35.91

-0.08%↓

ARGX

649

+0.53%↑

VIE

33.44

+0.3%↑

Search

Syensqo SA

Fermé

47.62 0.27

Résumé

Variation du prix de l'action

24h

Actuel

Min

47.36

Max

48.84

Chiffres clés

By Trading Economics

Revenu

-204M

-164M

Ventes

-229M

1.3B

Rendement du dividende

3.31

Marge bénéficiaire

-12.34

Employés

13,000

EBITDA

44M

343M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.31%

2.45%

Prochains Résultats

15 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-3B

5B

Ouverture précédente

47.35

Clôture précédente

47.62

Syensqo SA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

6 avr. 2026, 23:17 UTC

Résultats

Samsung Forecasts Record First-Quarter Operating Profit

6 avr. 2026, 23:00 UTC

Actions en Tendance

Stocks to Watch: Health Insurers, Mawson, Owlet

6 avr. 2026, 22:13 UTC

Principaux Mouvements du Marché

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 avr. 2026, 21:46 UTC

Acquisitions, Fusions, Rachats

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 avr. 2026, 17:09 UTC

Principaux Mouvements du Marché

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 avr. 2026, 16:56 UTC

Principaux Événements d'Actualité

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 avr. 2026, 14:47 UTC

Principaux Mouvements du Marché

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 avr. 2026, 23:58 UTC

Market Talk
Principaux Événements d'Actualité

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 avr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 avr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 avr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 avr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 avr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 avr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 avr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 avr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 avr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 avr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 avr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 avr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 avr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 avr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 avr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 avr. 2026, 18:36 UTC

Acquisitions, Fusions, Rachats

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 avr. 2026, 17:59 UTC

Market Talk
Principaux Événements d'Actualité

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 avr. 2026, 17:13 UTC

Acquisitions, Fusions, Rachats

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 avr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 avr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 avr. 2026, 14:59 UTC

Résultats

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparaison

Variation de prix

Syensqo SA prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Syensqo SA

Syensqo SA/NV operates as a science company worldwide. It operates through Materials, and Consumer & Resources segments. The company offers amine ether, amines, fatty amines, and specialty amines; antioxidants and stabilizers; composites; flavors and fragrances, such as vanillin, ethylvanillin, natural vanillin, and cyclopentanone; lithium salts, lithium cryolite, and lithium chemicals; diphenols and hydrocarbon monomers; and phosphorus specialties. It also provides biobased polymers, inverse emlusion polymers, monomers, specialty monomers, and synthetic polymers; solvents, including green solvents, flame retardants, and hydrocarbon; specialty chemicals; specicalty polymers comprising aromatic polyamides, aromatics, sulfones, fluorinated fluids, fluoropolymers, high performance polyester, polyethylene, polyolefin, and polyvinylidene chloride; and amphoteric, anionic, blend, cationic, and non-ionic surfactants. The company's products are used for transportation, aerospace, agro and feed, automotive, building, chemical, consumer goods, electronics, environment and energy, food, healthcare, home personal care, industrial, mining, and oil and gas markets. Syensqo SA/NV was founded in 1863 and is headquartered in Brussels, Belgium.
help-icon Live chat